AstraZeneca vaccine | Page 3 | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Wednesday
May 21, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
WEDNESDAY, MAY 21, 2025

AstraZeneca vaccine

A vial with the AstraZeneca's coronavirus disease (COVID-19) vaccine is pictured in Berlin, Germany, March 16, 2021. REUTERS/Hannibal Hanschke
Coronavirus chronicle

Health experts pore over AstraZeneca safety data as Europe reels from vaccine suspensions

The WHO and EMA had earlier joined AstraZeneca in saying there is no proven link, but some experts said the episodes of blood clots, bleeding and low platelet counts in younger people seemed to...

File Photo: A member of the medical staff holds a vial of the Oxford-AstraZeneca COVID-19 vaccine at the Foch hospital in Suresnes, near Paris, France, February 8, 2021. REUTERS/Benoit Tessier
Coronavirus chronicle

EU regulator ‘convinced’ AstraZeneca jab benefits outweigh risks

File Photo: A logo is pictured on the headquarters of the World Health Orgnaization (WHO) in Geneva, Switzerland, June 25, 2020. Photo: Reuters/Denis Balibouse
Coronavirus chronicle

WHO: Vaccine rollout unaffected by concerns over AstraZeneca

Vials labelled "Astra Zeneca COVID-19 Coronavirus Vaccine" and a syringe are seen in front of a displayed AstraZeneca logo, in this illustration photo taken March 14, 2021. REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

Netherlands halts use of AstraZeneca Covid-19 vaccine

FILE PHOTO: A test tube labelled with the Vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

Spanish regions halt AstraZeneca shots over blood clot concerns

There was also a mock drill of conducting vaccination and reporting and review meetings at the block, district and state levels. Picture: Hindustan Times
Coronavirus chronicle

No clotting case in India after Oxford dose

A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

WHO insists AstraZeneca vaccine safe as jab faces new setbacks

An AstraZeneca spokesman said: "There have been no confirmed serious adverse events associated with the vaccine," adding that all batches are subject to strict and rigorous quality controls. (Representative Image)(AP)
Coronavirus chronicle

Austria suspends AstraZeneca vaccine as precaution after woman's death

Modi's ministers choose 'Made in India' vaccine over AstraZeneca
Coronavirus chronicle

Modi's ministers choose 'Made in India' vaccine over AstraZeneca

A healthcare worker prepares to administer a dose of the Oxford University-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (COVID-19), in Santiago, Dominican Republic February 17, 2021. REUTERS/Ricardo Rojas/File Photo
Coronavirus chronicle

UK to receive 10 million AstraZeneca Covid-19 vaccine doses from India's Serum Institute

A health worker prepares an injection with a dose of Astra Zeneca coronavirus vaccine, at a vaccination centre in Westfield Stratford City shopping centre, amid the outbreak of coronavirus disease (COVID-19), in London, Britain, February 18, 2021. REUTERS/Henry Nicholls
Coronavirus chronicle

UK finds vaccines 80% effective at preventing risks in over-80s

The AstraZeneca logo is pictured outside the AstraZeneca office building in Brussels as part of the coronavirus disease (COVID-19) vaccination campaign, Belgium, January 28, 2021. REUTERS/Johanna Geron
Global Economy

AstraZeneca has sold its stake in Moderna for more than $1 billion: The Times

French President Emmanuel Macron. Photo: Reuters
Coronavirus chronicle

Macron says he would take AstraZeneca vaccine if it was offered

  • Show More
  • loading...
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net